Glia Nova Nyrt.
- Introduction
- Trading data
- Financials
- Shareholders, management
- Publications
- Product features
| Full Name | Glia Nova Nyilvánosan Működő Részvénytársaság | ||||||
| Short name | Glia Nova Nyrt. | ||||||
| Sector | Biotechnology | ||||||
| Contact |
HU-1045 Budapest, Berlini utca 47-49.
Phone: +36-30-456-5432
Fax: -
Web: www.glianova.hu
|
||||||
| Investor Relations | |||||||
| Auditor | CMT Audit LLC. (Auditor: Móri Ferencné) | ||||||
| Business activity | Glia Nova Nyrt., through its subsidiaries, has been engaged in the implementation of innovation projects since 2003, with a particular focus on biotechnology, agriculture, and agroinformatics. The company carries out a wide range of agricultural and infrastructural developments, placing special emphasis on sustainability and environmental protection. Glia Nova Nyrt. recently acquired a majority stake in Albitech Kft., a leading player in agricultural algae production and a pioneer in biotechnological innovation in Hungary. As part of the Emerging Settlements Program, the company is a long-term partner of the Maltese Charity Service in Tarnabod. Within the framework of the Tarnabod 2.0 Factory of the Future project, Glia Kft.s (subsidiary) technological developments support the local communitys economic advancement through the creation of sustainable economic models and environmentally friendly practices. | ||||||
| Listed securities of the issuer |
|
| Basic Information | |
|---|---|
| Ticker | GLIA |
| ISIN | HU0000214358 |
| Date of listing | 08 Apr 2025 |
| Currency of trading | HUF |
| Face Value | 100 HUF |
| Number of securities listed | 10,294,604 |
| Market Capitalisation (HUF million) | 669 |
| P/BV | |
|---|---|
| P/BV* | 0.279 |
* Calculating based on the capitalisation of the actual series only
| Performance | |
|---|---|
* annualized yield
Key annual data
audited, non-consolidated, in compliance with has; Business Year: January 1 - December 31| 20241 | 20252 | |
|---|---|---|
| (thousand HUF) | (thousand HUF) | |
| Total revenues | 0 | 0 |
| Operating Profit (EBIT) | -3,782 | -19,312 |
| Net income from financial activities | -35 | -465 |
| Profit before tax | -3,782 | -19,778 |
| Profit after tax | -3,782 | -19,785 |
| Dividend per (ordinary) share | 0 HUF | 0 HUF |
| Fixed Assets | 2,415,814 | 2,410,654 |
| Total liabilities | 46,027 | 43,241 |
| Share capital | 1,029,460 | 1,029,460 |
| Shareholders equity | 2,417,924 | 2,398,139 |
| Total assets | 2,465,451 | 2,443,880 |
| Number of employees (at business year end) | 1 | 0 |
- (1) audited, consolidated, in compliance with has; Business Year: January 1 - December 31
- (2) audited, non-consolidated, in compliance with has; Business Year: January 1 - December 31
Selected financial ratios
Ratios are based on data submitted by the company| 2024 | 2025 | |
|---|---|---|
| Equity Ratio | 0.02 | 0.02 |
| Return on equity (ROE) | -0 | -0.01 |
| Return on assets (ROA) | -0 | -0.01 |
Mid-year reports
non-audited, consolidated, IFRS; Business Year: January 1 - June 30| Key P&L Figures | Jan 2025 - Jun 20251 |
|---|---|
| (thousand HUF) | |
| Net sales | 0 |
| Operating profit (EBIT) | -6,545 |
| Net income from financial activities | -9,146 |
| Profit before tax | -6,609 |
| Profit after tax | -6,669 |
| Key Balance Sheet Items | 30 Jun 2025 |
|---|---|
| (thousand HUF) | |
| Fixed Assets | 2,415,814 |
| Intangible Assets | 0 |
| Tangible assets | 85,112 |
| Invested financial assets | 40,651 |
| Current Assets | 41,360 |
| Inventory | 0 |
| Total assets | 2,457,174 |
| Shareholders equity | 2,411,370 |
| Share capital | 1,029,460 |
| Long-term liabilities | 0 |
| Short-term liabilities | 45,804 |
| Total liabilities and shareholders equity | 2,457,174 |
- (1) non-audited, consolidated, IFRS; Business Year: January 1 - June 30
| Shareholders exceeding 5% stake with respect to the listed series | ||
|---|---|---|
| Name | Shareholding (%) | Share piece |
| Propriété Kft. | 60.24 | 6,201,239 |
| Free Float: 39.76% | Last update: 22 Feb 2026 | |
| Note: When determining the Free Float for a particular series, all the securities of the company shall be regarded to be publicly held other than (i) the stock of securities held by holders with direct holdings of more than 5% of the total number of securities, (ii) securities in the possession of custodians, provided the certificate available to the custodian verifies that the particular person holds more than 5% of the total number of securities outstanding belonging to the series. The value of the free float is based on the data provided by the issuer. | ||
| Management | |
|---|---|
| Management Board | BENCSIK Attila Kálmán (chairman), BENCSIKNÉ TARINA Krisztina, BALÁSDI-SZABÓ István, MÁRTON Balázs |
| Supervisory Board | LOZSÁDI Dániel Áron (chairman), Dr. BALÁZS Csaba László, JUHÁSZ Rudolf |
| Last update: 31 Aug 2026 | |
Note: Publications of this issuer are available in Hungarian only.
| Publication | Report |
|---|---|
| 04 Jun 2026 17:29 | Glia Nova Nyrt. - Éves Jelentés-2025 |
| 01 Oct 2026 21:46 | Glia Nova Nyrt. - 2026. I. Féléves jelentés |
| 04 Jun 2026 17:28 | Glia Nova Nyrt. - FT jelentés |
| Publication | Articles of Association |
|---|---|
| 03 Aug 2026 18:22 | Glia Nova Nyrt. -Alapszabály módosítás |
| Publication | Voting rights, registered capital |
|---|---|
| 30 Sep 2026 08:32 | Glia Nova Nyrt. - Szavazati jogok, alaptőke havi bejelentése |
| Name of security | Glia Nova Nyrt. Ordinary share |
| Issuer | Glia Nova Nyilvánosan Működő Részvénytársaság |
| Equity class | Ordinary share |
| Type of security | Registered |
| Form of security | Dematerialised |
| Code of security (ISIN) | HU0000214358 |
| Ticker symbol | GLIA |
| Face value | 100 HUF |
| Number of securities listed | 10,294,604 |
| Rights to dividends | Full year |
| Listing date | 08 Apr 2025 |
| First Trading Day | 29 Apr 2025 |
| Trading Unit | |
| Currency of trading | HUF |
| Trading time | |
| Listing price | 235.9 |
| Date of Issue | 04 Jun 2023 |